Cannabis’ Coronavirus Disappointment

2020-05-14 23_13_35-WindowCannabis investors who bet that marijuana stocks would benefit from an increase in demand for cannabis products during the coronavirus lockdowns have largely been disappointed. As today’s article notes, even if demand for marijuana did rise with people stuck at home, “it hasn’t translated to gains for major cannabis producers.” Is more disappointment ahead from marijuana stocks? For more, CLICK HERE.

Read More

Micro-Caps, Mega Gains?

2020-05-10 19_59_56-low angle photo of flag of U.S.A photo – Free City Image on UnsplashMorgan Stanley’s chief US equity strategist believes that stocks hit their true bottom on March 23rd – and that the current rally could well lead to a true recovery. To prepare for the next bull run, he’s advising clients to buy into small-cap stocks, so today’s article highlights “three micro-cap penny stock companies with super-low entry costs (a dollar per share or less) and huge upside potential (greater than 90% in the year to come).” For more, CLICK HERE.

Read More

3 Potential “Game-Changer” Biotech Stocks With Triple-Digit Upside Potential

2020-05-08 20_58_20-Unrecognizable chemist taking liquid with pipette from test tube in modern labor“Veteran players of the stock picking game know that biotechs are capable of delivering a win at what feels like the drop of a hat,” notes the author of today’s article, who proceeds to highlight three biotech stocks, identified by investment firm Wedbush, with the potential to be game-changers. For these three Buy-rated biotech stocks with triple-digit upside potential, CLICK HERE.

Read More

Take Advantage Of This Stock Market Anomaly – And Outperform The Market!

2020-05-05 22_27_12-WindowToday’s article examines a particular, well-established anomaly of the stock market – the short-term reversal effect – and how active traders can use a simple rotational strategy to take advantage of this anomaly and significantly outperform the market. For more on the short-term reversal anomaly, the strategy to benefit directly from it – and whether traders can still use this strategy in these unusual times – CLICK HERE.

Read More

2 Cheap Healthcare Stocks With Growth Drivers For A Rebound

2020-05-03 19_49_27-group of doctors walking on hospital hallway photo – Free Human Image on UnsplasToday’s article highlights two cheap healthcare stocks that, while having suffered so far this year, have growth drivers at hand that should set them up for rebounds going forward: “The first of these great deals, a pharmaceutical company, has a blockbuster on the market, a newer drug with growing sales, and possible drug approvals in the coming months. And the second great deal is a diagnostics player with a huge opportunity in cancer screening.” For more, CLICK HERE.

Read More

Ahead Of Q1 Earnings, Goldman Sachs Is Bullish On These 4 Biotech Stocks

2020-04-30 20_38_05-woman holding laboratory appratus photo – Free Public health Image on UnsplashWith all the attention the top-performing health care sector, and biopharmaceutical stocks in particular, are receiving, which biotech stocks are worth a look ahead of their first-quarter earnings reports? Analysts at Goldman Sachs have identified four that they are bullish on, and today’s article notes that “While their shares only suited for aggressive growth accounts with a high-risk profile, none of these companies is a proverbial one-trick pony. In addition, they all are potential takeover candidates.” For more, CLICK HERE.

Read More

Top Sectors & Stocks For A Return To Selective Stock Picking

2020-04-29 23_28_08-person using laptop on white wooden table photo – Free Business Image on UnsplasNoting that we’re “beginning to see selectivity creep back into the marketplace following a period of indiscriminate buying”, the author of today’s article proceeds to identify the best sectors right now across large-cap, mid-cap and small-cap stocks, as well as a slew of “top scoring stocks” from those select sectors that may be the best buys for stock pickers right now. For more, CLICK HERE.

Read More

Post Sell-Off And Snap-Back, Is It Now A Stock-Pickers’ Market?

2020-04-26 20_21_47-Man in Black Coat, White Dress Shirt and Black, Gray and White Necktie · Free StAfter the coronavirus-driven market selloff – and subsequent snap-back – the pivotal question right now, suggests the author of today’s article, is whether this is now a stock-pickers’ market, or whether macro matters most and all stocks are essentially equal. And if it is a stock-pickers’ market, what are some stocks worth picking? For how a panel of stock-pickers are answering these questions – and more – CLICK HERE.

Read More

Ultra Risk Could Lead To Ultra Riches With These 3 Biotech Stocks

2020-04-23 21_33_04-WindowWhen it comes to the three clinical-stage biotech stocks highlighted in today’s article, the author declares that, while they are all “relatively small at the moment…they have potential blockbuster drugs in development that could send their stock prices screaming higher.” For these three biotech stocks whose ultra risk could lead to ultra riches with clinical trial success, CLICK HERE.

Read More